Bellerophon Therapeutics, Inc. Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Bellerophon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Bellerophon Therapeutics, Inc. for September 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27 2018 | BLPH | Bellerophon Therap ... | Edmonds Amy | VP Clinical Operati ... | Grant | A | 0.00 | 82,243 | 0 | 176,043 | 93.8 K to 176 K (+87.68 %) |
| Sep 27 2018 | BLPH | Bellerophon Therap ... | Dekker Martin | VP of Engineering & ... | Grant | A | 0.00 | 82,243 | 0 | 151,753 | 69.5 K to 151.8 K (+118.32 %) |
| Sep 27 2018 | BLPH | Bellerophon Therap ... | Shah Parag Suresh | VP Proj Mgmt & Dist ... | Grant | A | 0.00 | 78,505 | 0 | 131,599 | 53.1 K to 131.6 K (+147.86 %) |
| Sep 27 2018 | BLPH | Bellerophon Therap ... | Fernandes Peter | Chief Regulatory & ... | Grant | A | 0.00 | 119,626 | 0 | 222,302 | 102.7 K to 222.3 K (+116.51 %) |
| Sep 27 2018 | BLPH | Bellerophon Therap ... | Tenenbaum Fabian | Chief Executive Off ... | Grant | A | 0.00 | 224,299 | 0 | 479,282 | 255 K to 479.3 K (+87.97 %) |
| Sep 27 2018 | BLPH | Bellerophon Therap ... | Korner Assaf | CFO | Grant | A | 0.00 | 99,065 | 0 | 99,065 | 0 to 99.1 K |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.18 | 60,000 | 70,944 | 7,386,163 | 7.3 M to 7.4 M (+0.82 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.23 | 75,000 | 92,250 | 7,326,163 | 7.3 M to 7.3 M (+1.03 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.19 | 75,000 | 89,160 | 7,251,163 | 7.2 M to 7.3 M (+1.05 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.18 | 60,000 | 70,944 | 7,386,163 | 7.3 M to 7.4 M (+0.82 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.23 | 75,000 | 92,250 | 7,326,163 | 7.3 M to 7.3 M (+1.03 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.19 | 75,000 | 89,160 | 7,251,163 | 7.2 M to 7.3 M (+1.05 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.15 | 75,000 | 85,913 | 7,176,163 | 7.1 M to 7.2 M (+1.06 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.14 | 200,000 | 228,840 | 7,101,163 | 6.9 M to 7.1 M (+2.90 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.22 | 200,000 | 243,640 | 6,901,163 | 6.7 M to 6.9 M (+2.98 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.15 | 75,000 | 85,913 | 7,176,163 | 7.1 M to 7.2 M (+1.06 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.14 | 200,000 | 228,840 | 7,101,163 | 6.9 M to 7.1 M (+2.90 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.22 | 200,000 | 243,640 | 6,901,163 | 6.7 M to 6.9 M (+2.98 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.90 | 60,000 | 53,742 | 6,701,163 | 6.6 M to 6.7 M (+0.90 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.84 | 50,000 | 42,095 | 6,641,163 | 6.6 M to 6.6 M (+0.76 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.85 | 50,000 | 42,325 | 6,591,163 | 6.5 M to 6.6 M (+0.76 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.90 | 60,000 | 53,742 | 6,701,163 | 6.6 M to 6.7 M (+0.90 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.84 | 50,000 | 42,095 | 6,641,163 | 6.6 M to 6.6 M (+0.76 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.85 | 50,000 | 42,325 | 6,591,163 | 6.5 M to 6.6 M (+0.76 %) |